Authors
Loading...
Randomized trial identifies DGCR8's unique heme-binding properties, suggesting implications for microRNA maturation.
Barr et al. (2011) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: